ATAI

ATAI Life Sciences BV

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

ATAI Life Sciences BV Stock Price

Vitals

Today's Low:
$3.0850
Today's High:
$3.4300
Open Price:
$3.3000
52W Low:
$2.6
52W High:
$17.75
Prev. Close:
$3.3800
Volume:
919885

Company Statistics

Market Cap.:
$0.521 billion
Book Value:
1.927
Revenue TTM:
$0.001 billion
Operating Margin TTM:
-21086%
Gross Profit TTM:
$0.020 billion
Gross Profit TTM:
$0.020 billion
Profit Margin:
0%
Return on Assets TTM:
-20.5%
Return on Equity TTM:
-49.7%

Company Profile

ATAI Life Sciences BV had its IPO on 2008-01-29 under the ticker symbol ATAI.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. ATAI Life Sciences BV has a staff strength of 0 employees.

Stock update

Shares of ATAI Life Sciences BV opened at $3.3 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $3.09 - $3.43, and closed at $3.14.

This is a -7.1% slip from the previous day's closing price.

A total volume of 919,885 shares were traded at the close of the day’s session.

In the last one week, shares of ATAI Life Sciences BV have increased by +4.67%.

ATAI Life Sciences BV's Key Ratios

ATAI Life Sciences BV has a market cap of $0.521 billion, indicating a price to book ratio of 1.597 and a price to sales ratio of 782.05.

In the last 12-months ATAI Life Sciences BV’s revenue was $0.001 billion with a gross profit of $0.020 billion and an EBITDA of $-0.140 billion. The EBITDA ratio measures ATAI Life Sciences BV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ATAI Life Sciences BV’s operating margin was -21086% while its return on assets stood at -20.5% with a return of equity of -49.7%.

In Q2, ATAI Life Sciences BV’s quarterly earnings growth was a negative -96.8% while revenue growth was a positive 0%.

ATAI Life Sciences BV’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-1.399 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ATAI Life Sciences BV’s profitability.

ATAI Life Sciences BV stock is trading at a EV to sales ratio of 278.92 and a EV to EBITDA ratio of -1.324. Its price to sales ratio in the trailing 12-months stood at 782.05.

ATAI Life Sciences BV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

ATAI Life Sciences BV ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

ATAI Life Sciences BV ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

ATAI Life Sciences BV’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, ATAI Life Sciences BV's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, ATAI Life Sciences BV paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$3.14
52-Week High
$17.75
52-Week Low
$2.6
Analyst Target Price
$23.47

ATAI Life Sciences BV stock is currently trading at $3.14 per share. It touched a 52-week high of $17.75 and a 52-week low of $17.75. Analysts tracking the stock have a 12-month average target price of $23.47.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About ATAI Life Sciences BV

The stock symbol (also called stock or share ticker) of ATAI Life Sciences BV is ATAI

The IPO of ATAI Life Sciences BV took place on 2008-01-29

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$0.69
0
+0.73%
$4.84
0.03
+0.62%
$7.36
-0.15
-2%
$0.42
-0.05
-10.18%
$3.99
-0.82
-17.05%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

ATA Creativity Global provides educational services to students in China. The company is headquartered in Beijing, China.

Address

180 VARICK STREET, NEW YORK, NY, US